Chamomile (Apigenin-standardized)
Also sold as: Chamomile Supplements
The most-drunk sleep herb in the world, and one of the few with an actual randomized trial behind it rather than just tradition.
Chamomile (Apigenin-standardized) quick facts
| Suggested dose | Extract: 400–1,500 mg standardized to 1.2% apigenin. Tea delivers a small fraction of the trial dose. |
| How often | Daily, or as needed |
| Who it's for | Mild anxiety and sleep onset. Realistic expectations. |
A standardized extract trial showed reduced generalized anxiety scores over eight weeks, which is better evidence than most calming herbs manage. Meaningfully weaker than a pharmaceutical and correspondingly safer. It is in the ragweed family, so anyone with that allergy should be cautious, and it has mild anticoagulant activity worth knowing about before surgery.
How Chamomile (Apigenin-standardized) actually works
Delivers apigenin in its traditional matrix alongside other flavonoids and volatile oils. The GABA-A benzodiazepine-site binding is the primary proposed mechanism; the standardized extract concentrates it well above what a tea bag provides, which is the difference between the trial material and the drink.
Where to get Chamomile (Apigenin-standardized)
Find Chamomile (Apigenin-standardized) on iHerb →The evidence for Chamomile (Apigenin-standardized)
Graded by what exists behind each claim.
✅ Clinically validated
- An 8-week RCT of 1,500 mg/day standardized extract in generalized anxiety disorder found a clinically meaningful reduction in anxiety scores versus placebo.
- A longer-term trial found chamomile reduced GAD relapse rates.
- Sleep trial results are more mixed — improved subjective sleep quality in elderly and postnatal populations, weaker effects in general insomnia.
📊 Correlative data
- One of the most widely consumed herbal teas in the world with millennia of documented use for sleep, which is about as much population-scale tolerability data as a botanical can accumulate. Asteraceae allergy is the documented caution.
🧪 Theoretical / extrapolated benefits
- Apigenin binds benzodiazepine sites on the GABA-A receptor with low affinity — the same site as diazepam, at a vastly lower potency.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Chamomile (Apigenin-standardized) actually does
The flower does not contain the active molecule. It contains its sugar-bound precursor, and something has to cut the sugar off. Matricaria recutita stores its flavones overwhelmingly as glycosides - apigenin-7-O-glucoside and the malonylated and acetylated derivatives of it - because a sugar-bearing molecule is water soluble and can be stored in the plant vacuole. The compound that binds a receptor in a brain is the aglycone, apigenin, molecular weight 270 daltons.
The deglycosylation step is the conversion this page is about. A glucoside is too polar to cross a membrane efficiently. It is hydrolyzed either by lactase-phlorizin hydrolase at the intestinal brush border or by bacterial beta-glucosidases in the colon, and only then is the aglycone available for absorption and for phase II conjugation. The bioavailability of apigenin from apiin-rich parsley in humans was measured precisely because that conversion cannot be assumed Meyer 2006, and the answer is that absorption is low and variable between people.
What the aglycone does when it arrives is well characterized. Apigenin is a ligand at central benzodiazepine receptors with anxiolytic activity, demonstrated for the compound isolated from Matricaria recutita flowers Viola 1995, and its broader pharmacological profile as a flavonoid from Matricaria chamomilla was characterized separately Avallone 2000. It binds at the benzodiazepine site of the gamma-aminobutyric acid type A receptor as a partial agonist with modest affinity, which is why the effect is mild and why it does not produce the amnesia, ataxia and dependence of a full agonist.
Modest affinity plus low bioavailability is the whole story of why a cup of tea is not a drug. The receptor occupancy achieved depends on the product of how much aglycone is liberated, how much of that is absorbed before conjugation, and how much crosses the blood-brain barrier. Each of those 3 fractions is well below 1, and they multiply.
Apigenin has a second pharmacology that has nothing to do with sleep and is worth knowing about. It inhibits CD38, the main NAD-consuming enzyme in mammalian tissue, and it inhibits CYP1A2 and several other cytochrome isoforms. The first is why apigenin appears in longevity formulas; the second is the origin of the drug interactions in the safety section below.
And chamomile is more than apigenin, which is why whole-extract trials and pure-compound pharmacology do not have to agree. The flower also carries alpha-bisabolol and chamazulene in its essential oil, and the coumarins herniarin and umbelliferone. Those contribute to the anti-inflammatory and antispasmodic effects traditionally ascribed to the plant, and none of them is measured by an apigenin standardization figure.
Cell, rodent, human — and where it stops
This is one of the few sleep botanicals with randomized controlled trials rather than tradition, and the trials are about anxiety more than about sleep.
What is established for anxiety. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita extract in generalized anxiety disorder is the anchor Amsterdam 2009, and long-term treatment was examined in a subsequent randomized clinical trial Mao 2016. Together they are a stronger evidence base than almost any other herb in the sleep category has.
What is established for sleep. A preliminary examination of efficacy and safety of a standardized extract for chronic primary insomnia is the direct sleep study, and its own title uses the word preliminary Zick 2011. That is the honest state of the sleep claim: promising, small, and not confirmatory.
In receptor pharmacology. The benzodiazepine-site ligand activity of apigenin was demonstrated for the isolated compound Viola 1995 Avallone 2000, in vitro and in rodents at doses given by injection.
Here is the specific obstacle, and it is a dose obstacle the card already names. The trials used 1,100 to 1,500 mg of a concentrated extract standardized to 1.2 percent apigenin, which is roughly 13 to 18 mg of total apigenin equivalents per day. A tea bag holds 1 to 3 g of dried flower, of which the apigenin glycoside content is a fraction of a percent and the aqueous extraction recovers only part of that. A cup of tea delivers perhaps a milligram or 2 of apigenin equivalents, an order of magnitude below the trial dose.
The second obstacle is the conversion step, and it varies between people. The parsley study measured what fraction of an ingested flavone glycoside becomes circulating aglycone and found it low Meyer 2006. If deglycosylation depends partly on colonic bacteria, then 2 people taking the same capsule are not receiving the same dose, and no trial has stratified for that.
Chamomile (Apigenin-standardized) — which form, and does it matter
The form question is what the 1.2 percent refers to, and it refers to the precursor rather than the drug. Standardization is performed on total apigenin or apigenin-7-glucoside content, and the molecule measured in the assay is largely the glycoside. The molecule that reaches a receptor is the aglycone after hydrolysis Meyer 2006. Two extracts with identical standardization figures can therefore deliver different aglycone exposure depending on the glycoside mix and on the gut that receives them.
Tea, tincture and standardized extract are 3 different doses. Aqueous infusion extracts the water-soluble glycosides poorly in the 3 to 5 minutes most people steep for, and it extracts the essential oil hardly at all unless the cup is covered - the volatile bisabolol and chamazulene leave with the steam. An ethanolic tincture captures more of the lipophilic fraction. The concentrated capsule is the only form matched to the trials Zick 2011.
German and Roman chamomile are different species with different chemistry. The trials used Matricaria recutita, German chamomile. Chamaemelum nobile, Roman chamomile, is a different plant with a different essential oil composition and is not the studied material. A label that says chamomile without a Latin binomial has not answered the question.
Apigenin sold as an isolated compound is a fourth form, and it is not the same product. A 50 mg apigenin capsule delivers several times the apigenin equivalents of the trial extract while delivering none of the bisabolol, chamazulene or coumarins. It is a reasonable thing to take and it is not chamomile, and the anxiolytic trials do not transfer to it Amsterdam 2009.
And the practical form advice follows from the numbers. Somebody wanting the trial effect needs roughly 1,100 to 1,500 mg of a 1.2 percent standardized extract, not a tea bag. Somebody wanting a pleasant bedtime ritual should have the tea and should not expect the trial result from it Mao 2016.
What would have to be true, and how you would know it was not
1. The anxiety prediction, on the timescale the trials found. A validated anxiety score at baseline, week 2 and week 8 on 1,500 mg of standardized extract. Prediction: a modest but measurable reduction by week 8, which is what the randomized work reports Amsterdam 2009 Mao 2016. Anything dramatic in week 1 is expectation, given the receptor affinity involved.
2. The sleep prediction, with the read-out that actually separates them. Sleep onset latency and night wakings from an actigraph or a consistent diary, for 2 weeks before and 4 weeks after. Prediction: onset latency shortens more than total sleep time increases, because a mild anxiolytic reduces the arousal that delays sleep rather than adding sleep Zick 2011.
3. The prediction that cuts against the product. Predict that tea produces no measurable change on either endpoint at any realistic consumption, because the apigenin equivalents delivered are an order of magnitude below the trial dose Meyer 2006. If tea works as well as the extract in a blinded comparison, the apigenin model on this page is wrong and something else in the flower is responsible.
4. The interaction prediction, which is a caffeine experiment. Apigenin inhibits CYP1A2, the enzyme that clears caffeine. Predict that a fixed afternoon coffee feels stronger and lasts longer on chamomile extract days than on control days. That is a crude, free read-out of a real enzyme effect and it is the tell for the warfarin interaction that matters more.
5. Predict no next-day impairment, and check it. A simple reaction-time test on waking, on extract nights and control nights. Prediction: no difference, because a partial agonist with modest affinity should not produce the residual sedation of a hypnotic Viola 1995 Avallone 2000. Measurable next-day impairment would mean the product contains something stronger than chamomile.
What nobody has tested yet
Nobody has run a confirmatory insomnia trial. The sleep study describes itself as preliminary Zick 2011 and no adequately powered replication has followed. The largest claim made for this product rests on the smallest study behind it.
Nobody has measured plasma apigenin after the trial dose. The bioavailability work is in a different flavone source Meyer 2006, and no study reports circulating apigenin after 1,500 mg of the standardized chamomile extract used in the anxiety trials. That is the number that would connect the pharmacology to the clinical result.
Nobody has tested the gut-conversion hypothesis. If bacterial beta-glucosidases contribute to deglycosylation, response should differ by microbiome composition and by recent antibiotic exposure. Nobody has stratified a chamomile trial that way, and it would be a cheap addition to an existing design.
And nobody has compared the extract against isolated apigenin. That 2-arm study would say whether the flower's other constituents contribute anything, and it would decide which of 2 products on the same shelf a buyer should choose Avallone 2000.
Chamomile (Apigenin-standardized) — its own safety story, not its category's
This is genuinely among the more benign items in the sleep category, and the risks that do exist are specific rather than vague. The trials report good tolerability at 1,100 to 1,500 mg daily Amsterdam 2009 Mao 2016, with no dependence, no withdrawal and no next-day impairment described.
The allergy is real and it is a family reaction. Chamomile is an Asteraceae, and cross-reactivity with ragweed, mugwort, chrysanthemum and other Compositae is documented. Reactions range from oral itching to anaphylaxis, and someone with significant ragweed allergy should treat a first dose accordingly.
The anticoagulant interaction has a documented mechanism and a case literature. Chamomile carries coumarins - herniarin and umbelliferone - and apigenin inhibits cytochrome isoforms including CYP1A2 and CYP2C9, the enzyme that clears the more active warfarin enantiomer. Bleeding events have been reported in warfarin users who added chamomile. That is a reason for anyone on warfarin to tell their anticoagulation clinic rather than to avoid the tea Avallone 2000.
Sedative additivity is the second interaction and it is predictable. A benzodiazepine-site partial agonist adds to benzodiazepines, z-drugs, alcohol and sedating antihistamines Viola 1995. The effect is mild and the addition is not.
And 2 practical cautions. Pregnancy, where traditional use as a uterine stimulant and an absence of controlled data mean the honest answer is to ask a clinician; and infants, where chamomile preparations have carried botulism risk when honey is involved and where dosing has no basis. Nothing here is medical advice or a diagnosis of insomnia or anxiety, and none of these statements has been evaluated by the Food and Drug Administration.
Sources read for this page
- Amsterdam JD, Li Y, et al. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. Journal of Clinical Psychopharmacology 2009 · PMID 19593179
- Mao JJ, Xie SX, et al. Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial. Phytomedicine 2016 · PMID 27912875
- Zick SM, et al. Preliminary examination of the efficacy and safety of a standardized chamomile extract for chronic primary insomnia: a randomized placebo-controlled pilot study. BMC Complementary and Alternative Medicine 2011 · PMID 21939549
- Viola H, et al. Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects. Planta Medica 1995 · PMID 7617761
- Avallone R, et al. Pharmacological profile of apigenin, a flavonoid isolated from Matricaria chamomilla. Biochemical Pharmacology 2000 · PMID 10751547
- Meyer H, Bolarinwa A, et al. Bioavailability of apigenin from apiin-rich parsley in humans. Annals of Nutrition and Metabolism 2006 · PMID 16407641
How you would know if it worked
There is no blood test for this one. That is not a criticism — it is a fact about the effect, and it changes how you should judge it.
- What to watch: Anxiety scores rather than sleep scores. The strong trial here is eight weeks at 1,500 mg of standardized extract in generalized anxiety disorder; the sleep results are the mixed ones. Watch daytime worry and physical restlessness, and treat any improvement in the nights as a downstream bonus.
- How long before it means anything: Eight weeks at the trial dose. This is the least acute product on the sleep shelf and the one most often written off early, because nobody waits two months on something they think of as a tea.
- What will fool you: The dose form. A cup of tea delivers a small fraction of what the trials used, so a lifetime of chamomile tea doing nothing tells you nothing about the extract. It also cross-reacts with ragweed allergy, which is the other thing people blame on their sleep when it is actually the plant.
Run it one variable at a time. Starting three things in one week means a result you cannot attribute, which is the same as no result.
Chamomile (Apigenin-standardized) — safety & side effects
- Drowsiness. Allergic reactions in people sensitive to ragweed, chrysanthemums, marigolds or daisies — chamomile is in the same family, and anaphylaxis has been reported.
- Additive sedation with alcohol, benzodiazepines, z-drugs, opioids and antihistamines. The combination impairs driving more than either alone and more than most people expect. Mild antiplatelet activity; caution with anticoagulants.
- Avoid in pregnancy at high doses — uterine-stimulating.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — Chamomile (Apigenin-standardized) in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside Chamomile (Apigenin-standardized)
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| TSH (Thyroid-Stimulating Hormone) | Thyroid disease disrupts sleep in both directions |
| Ferritin | Low iron drives restless legs, a common hidden cause |
| Vitamin D (25-Hydroxy) | Associated with sleep quality and commonly low |
| Magnesium, RBC | The form worth measuring if you're dosing magnesium |
The Sleep Quality & Recovery panel covers these in one order — 11 markers, $172.35 with the discount applied.
Check results you already have → · All 103 markers A–Z
Chamomile (Apigenin-standardized) — frequently asked questions
What is Chamomile (Apigenin-standardized)?
The most-drunk sleep herb in the world, and one of the few with an actual randomized trial behind it rather than just tradition.
What is the suggested dose of Chamomile (Apigenin-standardized)?
Extract: 400–1,500 mg standardized to 1.2% apigenin. Tea delivers a small fraction of the trial dose. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find Chamomile (Apigenin-standardized) dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy Chamomile (Apigenin-standardized)?
Coach Cam sources Chamomile (Apigenin-standardized) from vetted, top-rated brands on iHerb — use the buy link on this page.
What Chamomile (Apigenin-standardized) is used for
Chamomile (Apigenin-standardized) appears under 3 goals in the goal router.
Related Sleep supplements
Where this goes next
The pages here are the frameworks. The protocols — the dosing, the order to correct things in, the week-by-week schedule and what to retest — are inside Skool.